Growth Metrics

Gilead Sciences (GILD) Free Cash Flow Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.15%
Dec 31, 2025 12.47%
Sep 30, 2025 13.59%
Jun 30, 2025 -21.55%
Mar 31, 2025 5.50%
Dec 31, 2024 3.54%
Sep 30, 2024 11.26%
Jun 30, 2024 -11.14%
Mar 31, 2024 9.55%
Dec 31, 2023 -1.40%
Sep 30, 2023 -4.40%
Jun 30, 2023 11.50%
Mar 31, 2023 -4.50%
Dec 31, 2022 -1.19%
Sep 30, 2022 1.08%
Jun 30, 2022 -13.38%
Mar 31, 2022 -10.71%
Dec 31, 2021 -1.98%
Sep 30, 2021 -5.79%
Jun 30, 2021 -14.40%
Mar 31, 2021 -9.16%
Dec 31, 2020 -20.97%
Sep 30, 2020 -11.27%
Jun 30, 2020 -15.08%
Mar 31, 2020 -25.67%
Dec 31, 2019 -3.59%
Sep 30, 2019 -8.96%
Jun 30, 2019 -12.03%
Mar 31, 2019 -0.93%
Dec 31, 2018 26.08%
Sep 30, 2018 23.36%
Jun 30, 2018 7.05%
Mar 31, 2018 26.58%
Dec 31, 2017 42.16%
Sep 30, 2017 30.46%
Jun 30, 2017 22.11%
Mar 31, 2017 45.55%
Dec 31, 2016 28.77%
Sep 30, 2016 38.18%
Jun 30, 2016 39.14%
Mar 31, 2016 37.45%
Dec 31, 2015 51.66%
Sep 30, 2015 39.21%
Jun 30, 2015 51.70%
Mar 31, 2015 53.29%
Dec 31, 2014 25.19%
Sep 30, 2014 35.93%
Jun 30, 2014 46.72%
Mar 31, 2014 24.09%